Biomarkers in lung cancer screening: the importance of study design.

Baldwin, David R; Callister, Matthew E; Crosbie, Philip A; O'Dowd, Emma L; Rintoul, Robert C; Robbins, Hilary A; Steele, Robert J C

Baldwin, David R; Callister, Matthew E; Crosbie, Philip A; O'Dowd, Emma L; Rintoul, Robert C; Robbins, Hilary A; Steele, Robert J C.

Afiliação

Baldwin DR; Respiratory Medicine, Nottingham University Hospitals, Nottingham, UK david.baldwin@nottingham.ac.uk.
Callister ME; University of Nottingham, Nottingham, UK.
Crosbie PA; Leeds Teaching Hospitals, Leeds, UK.
O'Dowd EL; University of Leeds, St James's University Hospital, Leeds, UK.
Rintoul RC; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, UK.
Robbins HA; Manchester Thoracic Oncology Centre, North West Lung Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Steele RJC; Respiratory Medicine, Nottingham University Hospitals, Nottingham, UK.

Eur Respir J ; 57(1)2021 01.

Article em En | MEDLINE | ID: mdl-33446580

Assuntos

Detecção Precoce de Câncer; Neoplasias Pulmonares; Biomarcadores Tumorais; Humanos; Neoplasias Pulmonares/diagnóstico; Projetos de Pesquisa

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / Neoplasias Pulmonares Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google